Introduction 61
The sensory cells of the inner ear are equipped with stereocilia, which harbor a molecular 62 machinery that permits sound to be converted into electrical potentials. The protein radixin 63 appears to be an important component of this machinery, since radixin-deficient mice are 64 deaf 1 from an early age and mutations in the human RDX gene is a cause of non-syndromic filaments. Otoacoustic emissions were absent, and a younger sister was similarly affected 142 with symmetrical profound sensorineural hearing loss without otoacoustic emissions. Both 143 siblings had the same homozygous RDX variant. Neonatal hearing screening was not 144 performed in either case. 145 146 Overall, these clinical data show that patients with RDX mutations can have normal hearing 147 on the first days of life, but hearing sensitivity deteriorates thereafter. It is not clear why this 148 hearing loss develops, so we performed additional experiments to determine the functional 149 role of radixin. 150 151
Radixin expression in the hearing organ 152
To study radixin's influence on hearing and the role of the protein for stereocilia function 153 (Figure 2A ), we used temporal bone preparations isolated from guinea pigs ( Figure 2B ), a 154 species with low-frequency hearing similar to humans. In these isolated preparations, which 155 retain the passive mechanics of the hearing organ 15 , direct visualization of sound-evoked 156 stereocilia motion is possible in a nearly native environment ( Figure 2C and D, ref. 16 ), which 157 makes the preparation useful for investigating functional changes in stereocilia. However, 158
the presence and distribution of radixin has not previously been examined in guinea pig hair 159 cells, so we began by staining the mature organ of Corti with phosphospecific antibodies 160 targeting radixin's threonine 564 residue. 161 162 Immunofluorescence was observed in the stereocilia of the sensory outer and inner hair 163 cells, with the strongest labeling in the three rows of outer hair cells. Double-labeling with  164 fluorescently tagged phalloidin, which binds actin filaments ( Figure 2E , left column), was 165 used to locate stereocilia. These were intensely labeled by radixin antibodies (Figure 2E , 166 center and right columns), whereas no consistent radixin label was present in either the cell 167 bodies of the sensory cells, in their adjacent supporting cells, or in the synaptic regions of 168 the inner hair cells ( Figure 2F ). 169 170
Three-dimensional reconstructions of stereocilia ( Figure 2G ) showed that radixin labeling 171 was most intense in the mid-basal part of stereocilia and tapered off toward their tip. To 172 quantify this more precisely, we measured the fluorescence intensity of each probe as a 173 function of distance from the base of the hair bundle. Plots of the normalized fluorescence 174 profiles ( Figure 2H ) confirmed the stronger labeling near the base of stereocilia, unlike the 175 actin probe (phalloidin), which had similar labeling intensity through the length of the 176 stereocilia. 177 178
Since the actin probe had stronger emission, we were concerned that its fluorescence might 179 bleed through into the radixin channel. If this were the case, a linear relationship between 180 their fluorescence intensities is expected. However, no such relationship was found ( Figure  181 2I). This pattern of labeling is consistent with the one found in chick 17 and rat 18 inner ears, so 182 we conclude that guinea pigs are an adequate model for investigating the functional role of 183 radixin in the mature hearing organ. Next, we performed physiological measurements by 184 combining rapid confocal imaging of sound-evoked stereocilia motion with 185 electrophysiology, measurements of electrically evoked motion, fluorescence recovery after 186 photobleaching, and in vivo measurements of hearing sensitivity in animals treated with 187 radixin inhibitors. 188 189
Radixin influences stereocilia deflections 190
Having established that radixin is present in guinea pig hair cells, but not detectable in 191 supporting cells or in afferent neurons, we proceeded by examining the sound-evoked 192 responses of stereocilia. To label stereocilia, a double-barreled glass microelectrode with µm tip diameter was positioned close to the sensory cells. One electrode barrel was used for 194
introducing the fluorescent dye di-3-ANEPPDHQ, which stained stereocilia ( Figure 2C ) and 195 allowed their sound-evoked motion to be studied using time-resolved confocal imaging 19, 20 . 196 The other electrode barrel was used for delivering the radixin blocker DX-52-1, which 197 disrupts radixin's ability to link the actin cytoskeleton with the cell membrane (ref. 21, 22 ; 198 Figure 3A ). The loss of these interactions creates an effect similar to the truncating 199 mutations described in our patients. 200 201
After injecting a 1-mM solution of DX-52-1 dissolved in artificial endolymph, no 202 morphological changes were observed in stereocilia (except for minor alterations in the 203 brightness of the dye, Figure 3B ; note that the effective inhibitor concentration is reduced 204 because the injected solution is dissolved in the endolymph present in scala media), but the 205 injection changed the response to acoustic stimulation. Before DX-52-1 ( Figure 3C , left 206 graph), the base of the hair bundle (blue trajectory) had a different direction of motion than 207 the bundle tip (red trajectory). As a result of this difference, motion directed at scala 208 tympani (downwards in Figure 3C ) caused deflection of stereocilia toward the center of the 209 cochlear spiral (green trajectory). Ten to fifteen minutes after DX-52-1 ( Figure 3C , right 210 graph), sound-evoked displacement showed a minor but significant increase both at the 211 base and at the tip of the hair bundle. As a consequence, the sound-evoked deflection of the 212 hair bundle became larger (green trajectory in the right graph in Figure 3C ). In preparations 213 treated with vehicle alone (endolymph with 1.8% DMSO), neither morphology nor motion 214 trajectories changed ( Figure 3E and F). 215 216
The change induced by DX-52-1 was apparent 10 minutes after its application and 217 deflections remained elevated for at least 10 minutes thereafter ( Figure 3D, n=70 ). This 218 period of elevated sound-induced motion was followed by gradual recovery. Figure 3G -I 219
shows the hair bundle motion change across 70 preparations. At both the tip and the base of 220 the hair bundle, the motion amplitude increased (from 98 ± 15 nm to 116 ± 48 nm at the 221 base; p<0.0001, two-tailed paired t test, Figure 3G ; and from 90 ± 24 nm to 102 ± 40 nm at 222 the tip; p=0.04, Figure 3H ). Base motions were larger than the tip motion, as previously 223 described 8 . The change in the deflection amplitude was also significant (from 48 ± 21 nm to 224 56 ± 28 nm; p<0.0001, two-tailed paired t test; Figure 3I ). A significant difference was also 225 found when preparations injected with DX-52-1 were compared to those injected with 226 vehicle alone (Figure 3G and h; n= 27; two-tailed unpaired t test with Welch's correction).  227  228 In summary, the data shown in Figure 3B -I demonstrate that the radixin blocker DX-52-1 229
affected the sound-evoked motion of stereocilia, causing mildly increased deflection 230
amplitudes. This finding clearly cannot explain the hearing loss seen in patients, but it is 231 consistent with an effect of radixin on the stiffness of stereocilia. 232 233
Radixin affects electrically evoked motility 234
Outer hair cells contain a transmembrane protein, prestin, which confers upon the cell the 235 ability to rapidly change length in response to alterations in membrane potential 9 . This 236 electromotility is critical for hearing, and to further probe radixin's influence on hair cell 237 function, we measured electrically evoked motility using the rapid imaging technique 238 described above. The double-barreled microelectrode allowed us to apply 10-µA square 239
wave currents at the frequency of 5 Hz. These currents changed the electrical potential in 240 scala media, resulting in increased currents through the MET channels and increased force 241 production by outer hair cells 23 . 242 243
To show the change in electromotility evoked by DX-52-1, Figure 3J shows an outer hair cell 244 imaged in situ during electrical stimulation. The green channel was acquired during the 245 negative part of the square wave and the red channel during its positive phase. Before DX-246 52-1 application, most pixels overlapped, signifying low motility amplitude ( Figure 3J , top 247 right graph). After DX-52-1 was introduced, the green and the red channels separated, 248
implying an increased amplitude of electromotility ( Figure 3J , bottom right graph). These 249 changes were quantified through optical flow analysis. The time course ( Figure 3K ) shows 250 that the increase was evident 10 minutes after injection of the blocker and that the 251 amplitude remained elevated during 20 -25 minutes. A tendency to recovery was seen 252 thereafter. Overall, the change induced by DX-52-1 was statistically significant (from 101 ± 2 253 nm to 139 ± 12 nm; p=0.001, two-tailed paired t test; n=70), but this was not the case in 254 preparations injected with the vehicle alone ( Figure 3L ), where no change in motion 255 occurred. 256 257
Electrically evoked motility requires current passing through stereocilia and into the cell 258 bodies of the outer hair cells, as evidenced by decreased amplitudes of electromotility when 259 mechanically sensitive ion channels were blocked. Since we found an increased amplitude of 260 electrically evoked motion, these channels must still be able to pass current. 261 262
The increase in electromotility is consistent with a slightly decreased organ of Corti stiffness, 263
in agreement with the changes in sound-evoked stereocilia motion described above. 264
However, neither finding explains why hearing is lost in patients with RDX mutations. 265 266
The site of action of DX-52-1 is the stereocilia 267
To verify that DX-52-1 acts at the level of the stereocilia, we exploited the fact that radixin 268 connects the cell membrane with the underlying actin cytoskeleton. Hence, inhibition of 269 radixin is expected to remove an obstacle to diffusion, increasing the mobility of membrane 270 lipids. Lipid mobility can be measured using fluorescence recovery after photobleaching 271 (FRAP) 24 . In brief, a laser beam was focused to a submicron spot to bleach a region of 272 interest on the stereocilia ( Figure 3M ). Since diffusion will add new dye molecules to the 273 bleached area, the gradual recovery of fluorescence provides a measure of lipid mobility in 274 the membrane, as seen in the graph in Figure 3N . Here, a single-phase exponential model 275 (black line) was fitted to the averaged fluorescence recovery curve measured before (red 276 open circles) and 10 -15 minutes after DX-52-1 injection (blue circles). The fit parameters 277 revealed significantly faster fluorescence recovery during the 25-30 minutes that followed 278 inhibition of radixin ( Figure 3O ; 22 ± 2 s vs. 14 ± 1 s; p=0.02, two-tailed paired t test; n= 24). 279
Control injections in 14 preparations showed no significant change in the fluorescence 280 recovery time ( Figure 3N ). The normalized diffusion time was slightly longer after vehicle 281 injection ( Figure 3O ), but this change was not significant. 282 283
The changes in lipid mobility are consistent with disruption of membrane -cytoskeletal 284
interactions when radixin is blocked. 285 286
Radixin inhibition decreased cochlear microphonic potentials 287
During sound stimulation, ions permeate mechanically sensitive ion channels from the 288 surrounding fluid, generating extracellular electrical potentials that can be measured 289 through the electrode placed near the sensory cells. By tracking the amplitude of these 290 microphonic potentials over a range of stimulus frequencies, tuning curves were acquired. 291 292
Upon injection of DX-52-1, a decrease in the cochlear microphonic (CM) amplitude ( Figure  293 3P) was evident 10-15 minutes after the blocker injection, and the amplitude remained 294 depressed during the ensuing 30 -35 minutes ( Figure 3Q, n=70 ). On average, the CM 295 amplitude decreased from 124 ± 16 µV to 57 ± 9 µV, measured at the peak of each tuning 296 curve ( Figure 3R , p<0.0001, two-tailed paired t test). A significant difference in the amplitude 297 was also evident between preparations injected with DX-52-1 and the controls (p<0.0001, 298
two-tailed unpaired t test with Welch's correction; n= 13 controls). 299 300
The decrease in the CM amplitude means that the ability to convert sound into rapidly 301 alternating electrical potentials is impaired. This however is not due to a change in the 302 stimulation of stereocilia, because stereocilia deflections were slightly increased ( Fig. 3B -I). 303 Also, the decrease in the CM is not due to a blocking effect on mechanically sensitive 304 channels, as demonstrated by the increase in electrically evoked motion ( Fig. 3J -L), which 305 requires currents to pass through these channels into the hair cell soma. 306 307
Compound action potentials indicate loss of hearing sensitivity in vivo 308
To assess the influence of radixin on hearing sensitivity in vivo, we applied 1 µl of a 1 mM 309 DX-52-1 solution directly to the round window membrane of anesthetized guinea pigs while 310 measuring the amplitude of the auditory nerve compound action potential (CAP). The CAP 311
represents the summed response of auditory nerve fibers to acoustic stimulation, and is 312 most effectively elicited by high-frequency acoustic stimuli with rapid rise time. Ten to 40 313 minutes after the application of DX-52-1, the CAP amplitude decreased significantly 314 compared to control preparations where only the vehicle, perilymph with 1.8% DMSO, was 315 applied ( Figure 4A ). 316 317
Analysis of CAPs confirmed that hearing impairment was most pronounced at frequencies 318 between 8 and 16 kHz, while smaller changes were observed at other frequencies ( Figure  319 4B; n=18 for DX-52-1 vs 10 controls; p<0.0001; two-way ANOVA ). While the overall shape of 320 the CAP waveform remained similar after DX-52-1, there was a slight increase in the 321 response latency ( Figure 4C , E). Figure 4D demonstrates the time course for the change in 322 CAP N1 peak amplitude, with maximum amplitude change after about 20 -30 min. As shown 323
in Figure 4F , DX-52-1 decreased the amplitude of the cochlear microphonic potential (in 324 Figure 4F , the stimulus was a 90-dB SPL tone at 8 kHz). 325 326
The above data show that inhibition of radixin has effects that parallell the human data, 327
where RDX mutations caused profound hearing loss. 328 329
PAO-induced effects on stereocilia function 330
Radixin mediates interactions between the cytoskeleton and the cell's membrane, but 331 membrane attachment also requires the presence of PIP2, the synthesis of which can be 332 blocked by kinase inhibitors such as phenylarsineoxide (PAO; Figure 5A and ref. 6 ). Although 333 the rates of both fast and slow adaptation are affected by PAO 6 , its indirect inhibitory effect 334 on radixin can be used to confirm some of the DX-52-1 effects described above. 335 336
Injection of a 1-mM PAO solution into the endolymphatic space produced minor changes in 337 brightness of outer hair cell stereocilia, but no other morphological changes were evident 338 ( Figure 5B ). As seen in the example data in Figure 5C , the sound-evoked displacement at 339 both the tip of the stereocilia (red trajectory) and at their base (blue trajectory) decreased 340 following PAO. This decrease led to a reduced deflection amplitude (green trajectory; right 341 panel in Figure 5C ), even though the shapes of the motion trajectories remained similar. The 342 change in deflection amplitude was apparent 10 -15 minutes after PAO injection and the 343 amplitude continued to be reduced over the ensuing 40 minutes ( Figure 5D , n=35). 344 Aggregated data across 35 preparations are shown in Figure 5E -F. The decrease in motion 345 amplitude at the base of stereocilia was significant (from 97 ± 6 nm to 86 ± 22 nm; p<0.0001, 346 two-tailed paired t test; Figure 5E ) as were the change in displacement at their tips (from 80 347 ±19 nm to 72 ±22 nm; p<0.004, 2-tailed paired t test; Figure 5f ). The deflection amplitude 348 decreased from 46 ±21 nm to 37 ± 20 nm (p<0.0001, two-tailed paired t test; Figure 5G ). A 349 significant difference was also found when preparations injected with PAO were compared 350 to those injected with vehicle alone ( Figure 5G ; p=0.004, two-tailed unpaired t test with 351
Welch's correction).
353
Considering that DX-52-1 caused an increased motion amplitude in response to electrical 354 stimulation‚ we proceeded by examining the influence of PAO on electromotility. Color-355 coded data from an example preparation are shown in Figure 5H . In this case, images 356 acquired before and after PAO largely overlapped as demonstrated by the yellow color in 357 Figure 5H , indicating that PAO did not change electrically evoked organ of Corti motion. 358
Across 28 preparations, there was an increase from 93 ± 6 nm to 125 ±24 nm in the mean 359 amplitude of electrically evoked motion, but this change was not significant (p=0.20, two-360 tailed paired t test; Figure 5I ). Also, there was no significant difference between preparations 361
injected with the vehicle alone and those injected with PAO ( Figure 5I ). 362 363
Next, we used FRAP to look for changes in the membrane lipid diffusion kinetics after PAO 364
injection. Diffusion of di-3-ANEPPDHQ molecules within a defined ROI ( Figure 5J ) on the 365 stereocilia was measured. In the data shown in Figure 5K , a single-phase exponential model 366 (black line) was fitted to the averaged fluorescence recovery curve before (red open circle) 367 and 10 minutes after PAO injection (blue filled circles). The fit parameters revealed 368 significantly faster (from 21 ± 3 s to 16 ± 2 s; p=0.04, two-tailed paired t test; n=22; Figure 5L ) 369 diffusion during the ensuing 25 -30 minutes. A significant difference in the fluorescence 370 recovery time was also seen between preparations injected with PAO and the controls 371 ( Figure 5L ; p=0.03, two-tailed unpaired t test with Welch's correction). 372 373 PAO injection also led to a decrease in the CM amplitude ( Figure 5M ). The drop in the CM 374 amplitude was evident within 10-15 minutes after the injection, and there was no recovery 375 during the ensuing 30 -40 minutes ( Figure 5N ; n=33). On average, the CM amplitude 376
decreased from 145 ± 20 µV to 58 ± 10 µV, measured at the peak of each tuning curve 377 ( Figure 5O , p<0.0001, two-tailed paired t test). A significant difference in the amplitude was 378 seen between preparations injected with PAO and the controls ( Figure 5O ; p<0.0001, two-379 tailed unpaired t test with Welch's correction). 380 381
The change in lipid mobility evoked by PAO and the decrease in the CM amplitude are 382 consistent with the DX-52-1 findings; however PAO is unspecific (25) and will affect many 383 proteins found in stereocilia, which likely explains why the effects on sound-evoked motion 384 and on electromotility differ from those of DX-52-1. 385
Discussion

386
This study shows that radixin allows stereocilia to generate electrical potentials at acoustic 387 rates, making radixin necessary for cochlear amplification. The effects of radixin inhibition 388
are not due to a change in the stimulation of the sensory cells, since stereocilia deflections 389 showed a minor increase upon blocking radixin ( Fig. 3) . Similarly, the decrease in the 390 electrical potentials produced by the sensory cells is not due to inhibition of electromotility. 391
The increase in both sound-evoked deflections and in electromotility are however consistent 392 with a decrease in stereocilia stiffness. 393 394
Previous studies showed that hair cell stereocilia contain high levels of radixin 1, 4, 5 . Some 395 studies also demonstrated radixin labeling at the junctions between the supporting cells and 396 the hair cells 26 , but this was not evident in our experiments and no consistent labeling was 397 found in either neurons or in the cell bodies of the sensory cells. These results suggest that 398 radixin inhibition affects stereocilia function. This view is supported by findings from radixin 399 knockout mice, which show degeneration of stereocilia after the onset of hearing, but an 400 otherwise normal organ of Corti structure 1 . It appears that upregulation of ezrin, a protein 401 closely related to radixin, ensures normal early development of stereocilia but this 402 compensation mechanism subsequently fails. Hence, it is clear that radixin is critical during 403 the final phases of stereocilia development, but it continues to be expressed at high levels 404
through the life of the animal 1 suggesting an important physiological role that has remained 405 obscure. 406 407
Membrane-associated proteins such as radixin are often regulated by membrane lipids. 408
Radixin is activated only after positive regulation, which requires sequential binding of PIP2 409 and phosphorylation of threonine 564 27 . In hair cells, radixin is concentrated towards the 410 stereocilia base, where they insert into the cuticular plate. This taper region is a site of 411 mechanical stress during sound-evoked deflection 28 . Based on the findings of the present 412 study we propose that radixin, in addition to its role for channel function, contributes to the 413 regulation of stereocilia stiffness by linking the cytoskeleton more tightly to the membrane 414 inside this high-stress region. Findings evident after the inhibition of radixin and consistent 415 with this hypothesis include the increased lipid mobility ( Figure 3N , O), larger electrically 416 evoked motility ( Figure 3K , L), and larger sound-evoked stereocilia deflections ( Figure 3C , G-417 I) evident after inhibition of radixin. Due to the active, nonlinear mechanisms that amplify 418 sound-evoked motion in vivo 29, 30 , small changes in the mechanical properties of stereocilia 419
can have large effects on hearing organ performance. 420 421
However, the most dramatic effect of radixin inhibition was the reduction in sound-evoked 422 electrical potentials and in the amplitude of the CAP. This demonstrate a previously 423 unrecognized role of radixin in maintaining the amplitude of the mechanoelectrical 424 transduction current. Since we ( Figure 2 ) could detect no radixin expression either in 425 cochlear neurons or at the synaptic pole of the hair cells, the reduction of the CAP amplitude 426 is explained by an effect on the transduction process itself. This finding is supported by the 427 normal morphology of the organ of Corti in aged radixin knockout mice 1 , and with the 428 absence of detectable radixin expression in cochlear neurons 2 . 429 430
It is interestering that two of our patients had apparently normal hearing at birth, as shown 431 by them passing the newborn hearing screening program (the 2 siblings from pedigree 3 did 432 not undergo neonatal hearing screening). The subsequent development of hearing loss could 433 be due to a combination of reduced transduction currents and an inability to maintain 434 stereocilia structure, including their stiffness, in the long term in the absence of membrane-435 cytoskeletal links. However, hearing loss was profound in three of our patients and 436 moderate in one. At first sight, the removal of the start codon in exon 2 in this patient should 437 lead to complete absence of radixin expression. Due to an in-frame start codon present in 438 exon 3, it is however possible that a protein 11 amino acids shorter could be produced. We 439 speculate that such a shorter protein could retain some functionality, explaining the less 440 severe hearing loss in this patient and suggesting a clinically relevant genotype-phenotype 441 correlation for pathogenic RDX variants. Moreover, in one of our families copy number 442 variations contributed to the development of the hearing loss. It is important to identify such 443 variation during genetic testing, since it is a challenge to conventional next-generation 444 sequencing technologies. 445 446
The development of early onset hearing loss in children that passed newborn hearing 447 screening can confound both patients and their physicians causing diagnosis and 448
intervention to be postponed 31, 32, 33 . The resulting delays in speech and language 449 development may contribute to impairment of social skills and cognition 34 . No previous 450 study has examined the effect of radixin on stereocilia function. Therefore, understanding 451 the physiopathology of genes such as RDX and increasing our awareness of its contribution 452 to this burden of delayed diagnosis could improve the care of children with hearing 453 impairment. This is important, specially for siblings of already diagnosed patients. Therefore, 454 in these families, if a genetic diagnosis has not been obtained, close monitoring of the 455 siblings that have passed initial newborn hearing screening is mandatory. Importantly, the 456 fact that hearing appeared normal early in life could mean that a time window exists in the 457 event that therapies for restoring radixin functionality become available. In any case, those 458 potential, gene-specific, therapeutic opportunities will always be enhanced by an early and 459 comprehensive genetic diagnosis. 460 461
Materials and Methods 462
Ethics statement 463
The bone cutters which exposed the middle ear and the basal turn of the cochlea, including the 493 round window niche. Thereafter a small triangular or trapezoidal opening was made at the 494 apex using a #11 scalpel blade and a hole of 0.6 mm diameter was drilled at the base of the 495 cochlea using a straight point shaped pin. These openings allowed continuous perfusion of 496 oxygenated tissue culture medium through an external syringe tube connected to the basal 497 hole with a plastic microtube. Sound stimulation occurred through a calibrated loudspeaker 498
connected to the chamber with a plastic tube. Because of the immersion of the middle ear 499 and the opening at the apex, the effective sound pressure level was reduced by ~ 20 dB. The 500 values given throughout the text are corrected for this attenuation. The whole preparation 501 was maintained at room temperature (22 -24°C). The apical opening allowed confocal 502 imaging of the hearing organ and permitted insertion of a double-barrel glass  503  microelectrode filled with artificial endolymph-like solution (1.3 mM NaCl, 31 mM KHCO 3 , 23  504 µM CaCl 2 , 128.3 mM KCl, pH 7.4 and 300 mOsmol/kg adjusted with sucrose) into the scala 505 media through the Reissner's membrane (RM). This special electrode with septum is used for 506 cochlear microphonic recordings (CM), electrical stimulation, endocochlear potential 507 recordings (EP), bundle membrane staining and blockers delivery, as specified. 508 509
Reagents 510
The following stock solutions were prepared and further diluted in artificial endolymph to 511 the desired concentration to be used in the study. Di phosphate-buffered saline diluted to 1.0 mM for use. Note that the effective concentration 515 in the endolymph is lower than 1 mM because the agent is diluted in the scala media fluids 516 upon injection. Previous estimates suggest a 10x dilution factor (16 Electrophysiological recordings 529
Hair bundles were labeled with the membrane dye di-3-ANEPPDHQ which was dissolved in 530 endolymph solution and delivered by electrophoresis. This protocol ensured minimal dye 531 release into the scala media and produced strong labeling of stereocilia while preserving the 532 barrier function of Reissner's membrane (RM). Double-barrel microelectrodes with an outer 533 diameter of 1.5 mm were pulled with a standard electrode puller and beveled at 20 degrees 534 to a final resistance of ~4 -6 MΩ. The electrodes were mounted in a manual 535 micromanipulator at an angle of 30 degrees and positioned through the apical opening close 536 to the RM. The RM was penetrated using a hydraulic stepping motor. Current injections 537
were performed with a linear stimulus isolator (A395, World Precision Instruments) sending 538 positive steady state currents of up to + 14 µA. These currents restored the normal potential 539 around the hair bundles, leading to an increase of the currents through the MET channel, 540
and in the force produced by the hair cells. The endocochlear potential upon penetration of 541 RM was ~25-30 mV. Cochlear microphonic potentials were measured with an Ix1 amplifier 542 (Dagan Instruments) and digitized with a 24-bit A/D board (NI USB-4431, National 543 Instruments) at 10 kHz, using custom Labview software. Tuning curves were recorded in 544 response to a series of tone bursts at 60 dB SPL ranging from 60 to 820 Hz. The rise and fall 545 time was 1 ms, using a Hanning window. The samples signals were Fourier-transformed and 546 the peak amplitude plotted as a function of stimulus frequency. Before applying drugs, 547
tuning curve measurements were repeated every five minutes for 15-20 minutes to verify 548 that the response was stable. We therafter proceeded with other measurements, as 549 described in the text. 550 551
Time-resolved confocal imaging 552
To measure sound-evoked bundle motion, the hearing organ was faintly stained with 1 µl of 553 dye di-3-ANEPPDHQ added in the perfusion tube. Subsequently, the sensory hair cell 554 bundles were stained with di-3-ANEPPDHQ dissolved in the electrode solution and delivered 555
to the hair bundles iontophoretically with a current stimulus of 3-5 µA. The preparation was 556 stimulated acoustically near the bundles' best frequency (180 -220 Hz). The best frequency 557 was selected from the highest peak of the tuning curve of the cochlear microphonic 558 recordings. Image acquisition triggered both the acoustical and electrical stimulus. A series 559 of 37 images was acquired; each series requiring ~40 s for combined sound and current 560 stimulus. Custom Labview software ensured that every pixel in the image series had a known 561 phase both of the acoustic and electrical stimuli. To obtain images free from motion 562 artefacts, the softwared tracked the temporal relation between the pixels and the sound 563 stimulus. Image sequences free from motion artefacts were then reconstructed using a 564
Fourier series approach 19, 20 , to generate a sequence of 12 images at equally spaced phases 565 of the sine wave. Images for positive and negative current stimulation were also 566 reconstructed at 12 equally spaced phases. These image sequences were low-pass filtered 567 and subjected to optical flow analysis using a 2D version of the 3D algorithm described in ref. 568 20. To improve the signal-to-noise ratio, trajectories for all pixels in a 3x3 or 5x5 region were 569 averaged. For combined sound and electrical stimuli, current injection switched directly from 570 positive to negative at 5 Hz to avoid charge build-up in the scala media. 571 572
Blocker injection 573
For experiments in which blockers (DX-52-1 or PAO) were injected into the endolymphatic 574 space through the double-barrel microelectrode, one barrel of the electrode was filled with 575 the dye di-3-ANEPPDHQ dissolved in endolymph and the other contained the blocker 576 dissolved in endolymph. Pipettes had 1.5-3 µm tip diameter and were positioned 50-70 µm 577 from the hair bundles The blocker was pressure-injected by a 2 pound-per-square inch 578 pressure pulse lasting for 10 s. To verify the injection, a time series of confocal images, 60 to 579 100 s in length was acquired during each injection. Cochlear microphonic potentials (CM) 580
were recorded before and at 5-minute intervals after the injection. Sets of confocal images 581 of hair bundle displacement were recorded before (2 sets) and after injection (3-4 sets) and 582 continued every five minutes for the next 30-40 minutes of the experiment time at a 583 stimulus level of 80 dB SPL, 10 µA at 220 Hz best frequency. The argon laser line at 488 nm 584 and matching beamsplitter was used. To avoid bleaching, the laser power was set to the 585 minimum value consistent with an acceptable signal-to-noise ratio. 586 587
Fluorescence Recovery After Photobleaching (FRAP) 588 FRAP was performed by outlining a region of interest on the stained stereocilia membrane. 589
Following an acquisition of a series of 10 baseline images, a 2-μm spot on the stereocilia 590 membrane was photobleached by focusing the laser at a maximum power into the region of 591 interest 35 . The recovery of fluorescence was tracked by acquiring a series of 30 images at 1 592 or 3-s intervals over a time of 100 -140 s. The images were 256 x 512 pixels, 12-bit pixel 593 depth, with an integration time of 6.30 µs per pixel, and a pinole of 1.50 Airy units. Confocal 594 images were obtained before and 10 and 20 minutes apart after the blocker injection. 595
Statistical analysis was performed by fitting the experimental data to a one-phase decay 596 model. 597 598
Compound action potentials 599
To record compound action potentials (CAPs), animals were anaesthetized with an initial 600 dose of an intra-muscular injection of Xylazin (0.5ml/kg) and Ketalar (0.4ml/kg). Three to 601 four minutes after the animal was adequately anesthesized, the surgical site of the left bulla 602 was shaved and the animal placed on a thermostatically controlled heating blanket to 603 maintain a core body temperature of 38°C. Bupivacain (0.2ml/kg), a long-acting local 604 anaesthetic, was administered near the surgical site before skin incision. A retroauricular 605 incision was made in order to reach the temporal bone. Muscle and other soft tissues were 606 dissected, and the posterio-lateral part of the auditory bulla was opened to access the round 607 window niche. A thin Teflon-insulated Ag/AgCl silver ball recording electrode was placed in 608 close contact with the round window membrane. The electrode wire was fixed to the 609 temporal bone with dental cement to ensure the position of the recording electrode 610 remained stable throughout the experiment. The animal was then placed inside a sound-611 proof recording booth where an Ag/AgCl electrode was inserted subcutaneously at the 612 vertex of the skull. Cochlear compound action potentials were recorded sequentially from 613 the left ear of the animal. Standardized input-output functions were generated by varying 614 the intensity of stimulus (90 dB, 80 dB, 70 dB, 60 dB, 50 dB, 40 dB, 30 dB SPL in steps at 6 615 different frequencies 2 kHz, 4 kHz, 8 kHz, 12 kHz, 16 kHz, 20 kHz). The recorded evoked CAPs 616 signal was then filtered (high-pass frequency 3-5 Hz, low-pass frequency 3-5 kHz) and 617 amplified at a gain of 10 000 and stored for offline analysis. The responses to 200 repetitions 618 of each stimulus were averaged with a sampling rate of 100 kHz. Three sets of recordings 619
were obtained before the blocker application, and recordings were repeated at 5-min 620 intervals for the next 40 minutes after application of the blocker. Blockers were dissolved in 621 artificial perilymph (137 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 5 mM D-glucose, 5 622 mM HEPES, pH 7.4, 300 mOsmol/kg) and introduced on the round window membrane. All 623 recording software's were custom written in LabVIEW. 624 625
Surface preparation and immunofluorescence staining and imaging 626
Whole-mount preparations of the guinea pig organ of Corti were obtained as follows. 627
Temporal bones were removed, the bony bulla was opened to visualize the cochlea and two 628 small hole were made in the round window and at the apex. These openings allowed 629 perfusion of the sensory epithelium with phosphate-buffered saline solution (PBS). The 630 perilymphatic space was gently perfused with 4% paraformaldehyde in PBS. The sensory 631 epithelium was exposed by carefully removing the cochlear bone, the spiral ligament, and 632 the tectorial membrane. After washing the samples in PBS, they were permeabilized by 633 treating with, 0.3% Triton X-100 soaked in 3% bovine serum albumin (BSA, 0332-25G, VWR), 634 dissolved in PBS for 10 minutes at room temperature followed with one-time wash with PBS 635 for 5 minutes. Permeabilization was followed with blocking step by incubating the samples 636 for 2 hr in PBS containing 3% normal goat serum (NGS, 927503, BioLegend) and 3% BSA and 637 then stained overnight at 4°C with the primary monoclonal antibody (mouse anti-radixin, 638
ABNOH00005962-M06, Abnova) at a dilution of 1:500. Samples were then washed three 639 times with PBS for 10 minutes each, followed by a 2 hr incubation with a mixture of the 640 secondary antibody (goat anti-mouse Alexa Fluor® 488-conjugated IgG, ab150113 Abcam) 641
and Alexa Fluor 568 conjugated Phalloidin (A12380, ThermoFisher Scientific) at a dilution of 642 1:500. The antibody solutions were prepared in blocking solution. After three washes with 643 PBS for 20 minutes each, sections were readied for surface preparations. Sections of organ 644 of Corti starting from apex to base were carefully dissected and mounted on the glass slides 645 prepared earlier and cover slipped with mounting media Fluorosave reagent (345789, 646
Calbiochem). The slides were sealed and allowed to rest for ~2 h before proceeding with 647
imaging 703 704 Schematic diagram of outer hair cell stereocilia with radixin binding area. The top scheme represents the molecular interactions between radixin and F-actin cytoskeleton and the transmembrane protein CD44. In the hearing organ of animals where the radixin blocker DX-52-1 was not applied, the animals had normal hearing and stereocilia functions. Application of the blocker results in a disruption of the link between radixin and Factin. The animal had reduced hearing sensitivity and large effects on the OHC stereocilia functions were evident.
